Bionano Genomics, Inc. (BNGO) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Dec-31-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21
	10-Q	10-Q	8-K	10-Q	10-Q	10-K	10-Q	10-Q
Net income				-105.8	-92.4	-72.4	-61.2	-51.3
Depreciation and amortization				6.9	5.1	3.4	2.1	1.9
Stock-based compensation				18.5	14.5	9.7	5.4	3.0
Deferred taxes						-5.8
Change in working capital [+]				-8.1	-1.3	5.9	-6.0	-5.0
Accounts receivable				-0.4	-1.9	-0.5	0.0	0.2
Inventories				-24.4	-20.9	-15.9	-10.9	-6.8
Other current assets				-1.4	-0.6	-1.3	-2.5	-0.8
Accounts payable				3.9	4.7	6.8	2.2	-1.1
Accrued expenses				1.4	4.6	4.0	5.2	3.6
Other						12.9
Other operating activities				-12.1	-10.5	-12.7	1.4	1.9
Cash from operations				-106.4	-90.5	-71.9	-58.4	-49.4

Capital expenditures [+]				-1.1	-0.9	-0.8	-0.3	-0.1
Purchases of property and equipment				-1.1	-0.9	-0.8	-0.3	-0.1
Sales of property and equipment					0.2			0.1
Purchases of short-term investments, net				-163.0	-194.7	-226.9	-185.3
Purchases of short-term investments				-342.9	-328.3	-313.4	-205.3
Sales of short-term investments				180.0	133.7	86.5	20.0
Other cash from investing				-50.8	-50.6	-50.5
Cash from investing				-214.9	-246.1	-278.1	-185.6	-2.4

Issuance of common stock, net						342.7	364.7
Option exercises							10.1	24.9
Other cash from financing				2.1	-15.1	3.5	11.2	41.5
Cash from financing				15.9	-1.4	336.1	365.8	367.1

Free cash flow				-107.5	-91.5	-72.7	-58.8	-49.5
Per share (diluted)				($0.49)	($0.33)	($0.26)	($0.25)	($0.25)

Cash paid for interest				1.6	1.7	1.9	0.8	1.0